Kontour XiAn Medical Technology Co Ltd
SSE:688314
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| CN |
K
|
Kontour XiAn Medical Technology Co Ltd
SSE:688314
|
3.2B CNY |
Loading...
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
195.6B USD |
Loading...
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
178.9B USD |
Loading...
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
145.2B USD |
Loading...
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
124.8B USD |
Loading...
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
110.6B USD |
Loading...
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
47.2B EUR |
Loading...
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
52.7B USD |
Loading...
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
50.9B USD |
Loading...
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
46.3B USD |
Loading...
|
|
| US |
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
38.3B USD |
Loading...
|
Market Distribution
| Min | -416 945.9% |
| 30th Percentile | -1.5% |
| Median | 3.5% |
| 70th Percentile | 8.9% |
| Max | 17 382.1% |
Other Profitability Ratios
Kontour XiAn Medical Technology Co Ltd
Glance View
Kontour XiAn Medical Technology Co Ltd is a China-based company principally engaged in the research and development, production and sales of Class-III implantable medical device products. The Company's main products include titanium skull repair and fixation products for neurosurgical implantation and poly-ether-ether-ketone (PEEK) skull repair and fixation products, as well as sternum fixation products, neurospine products, supporting implant tools and other products. The Company's main products are used in neurosurgery skull repair fixation and cardiothoracic surgery sternal fixation. The Company distributes its products both in the domestic market and to overseas markets.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Kontour XiAn Medical Technology Co Ltd is 27.9%, which is below its 3-year median of 28.3%.
Over the last 3 years, Kontour XiAn Medical Technology Co Ltd’s Net Margin has decreased from 37.1% to 27.9%. During this period, it reached a low of 27.1% on Mar 31, 2024 and a high of 37.1% on May 30, 2022.
